USP37 Deubiquitinates CDC73 in HPT-JT Syndrome
Abstract
:1. Introduction
2. Results
2.1. Expression of CDC73 and Polyubiquitination
2.2. Screening of CDC73-Interacting Proteins
2.3. CDC73 Binds Directly to USP37
2.4. CDC73 Is Deubiquitinated by USP37
2.5. The Interaction Domains of CDC73 and USP37
2.6. Co-Localization of CDC73 with USP37
3. Discussion
4. Materials and Methods
4.1. Cell Culture, Transfection, and Antibodies
4.2. Construction of Expression Plasmids
4.3. Yeast Two-Hybrid Screening
4.4. RT-PCR
4.5. GST Pull-Down Assay
4.6. Co-Immunoprecipitation (co-IP) and Western Blotting
4.7. Immunofluorescence Assay
4.8. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sun, W.; Kuang, X.L.; Liu, Y.P.; Tian, L.F.; Yan, X.X.; Xu, W. Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Sci. Rep. 2017, 7, 15638. [Google Scholar] [CrossRef] [PubMed]
- Newey, P.J.; Bowl, M.R.; Cranston, T.; Thakker, R.V. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum. Mutat. 2010, 31, 295–307. [Google Scholar] [CrossRef] [PubMed]
- Carpten, J.D.; Robbins, C.M.; Villablanca, A.; Forsberg, L.; Presciuttini, S.; Bailey-Wilson, J.; Simonds, W.F.; Gillanders, E.M.; Kennedy, A.M.; Chen, J.D.; et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat. Genet. 2002, 32, 676–680. [Google Scholar] [CrossRef]
- Guarnieri, V.; Seaberg, R.M.; Kelly, C.; Jean Davidson, M.; Raphael, S.; Shuen, A.Y.; Baorda, F.; Palumbo, O.; Scillitani, A.; Hendy, G.N.; et al. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family. BMC Med. Genet. 2017, 18, 83. [Google Scholar] [CrossRef]
- Wang, P.; Bowl, M.R.; Bender, S.; Peng, J.; Farber, L.; Chen, J.; Ali, A.; Zhang, Z.; Alberts, A.S.; Thakker, R.V.; et al. Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice. Mol. Cell. Biol. 2008, 28, 2930–2940. [Google Scholar] [CrossRef] [Green Version]
- Rozenblatt-Rosen, O.; Hughes, C.M.; Nannepaga, S.J.; Shanmugam, K.S.; Copeland, T.D.; Guszczynski, T.; Resau, J.H.; Meyerson, M. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol. Cell. Biol. 2005, 25, 612–620. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yart, A.; Gstaiger, M.; Wirbelauer, C.; Pecnik, M.; Anastasiou, D.; Hess, D.; Krek, W. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol. Cell. Biol. 2005, 25, 5052–5060. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rodrigues, J.; Lydall, D. Paf1 and Ctr9, core components of the PAF1 complex, maintain low levels of telomeric repeat containing RNA. Nucleic Acids Res. 2018, 46, 621–634. [Google Scholar] [CrossRef] [Green Version]
- Xie, Y.; Zheng, M.; Chu, X.; Chen, Y.; Xu, H.; Wang, J.; Zhou, H.; Long, J. Paf1 and Ctr9 subcomplex formation is essential for Paf1 complex assembly and functional regulation. Nat. Commun. 2018, 9, 3795. [Google Scholar] [CrossRef]
- Woodard, G.E.; Lin, L.; Zhang, J.H.; Agarwal, S.K.; Marx, S.J.; Simonds, W.F. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 2005, 24, 1272–1276. [Google Scholar] [CrossRef] [Green Version]
- Yang, Y.J.; Han, J.W.; Youn, H.D.; Cho, E.J. The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res. 2010, 38, 382–390. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lin, L.; Zhang, J.H.; Panicker, L.M.; Simonds, W.F. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene. Proc. Natl. Acad. Sci. USA 2008, 105, 17420–17425. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mosimann, C.; Hausmann, G.; Basler, K. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell 2006, 125, 327–341. [Google Scholar] [CrossRef] [Green Version]
- Walls, G.V.; Stevenson, M.; Lines, K.E.; Newey, P.J.; Reed, A.A.C.; Bowl, M.R.; Jeyabalan, J.; Harding, B.; Bradley, K.J.; Manek, S.; et al. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: Model for the hyperparathyroidism-jaw tumour syndrome. Oncogene 2017, 36, 4025–4036. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bradley, K.J.; Bowl, M.R.; Williams, S.E.; Ahmad, B.N.; Partridge, C.J.; Patmanidi, A.L.; Kennedy, A.M.; Loh, N.Y.; Thakker, R.V. Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal. Oncogene 2007, 26, 1213–1221. [Google Scholar] [CrossRef] [Green Version]
- Cardoso, L.; Stevenson, M.; Thakker, R.V. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma. Hum. Mutat. 2017, 38, 1621–1648. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Deng, P.; Zhou, Y.; Jiang, J.; Li, H.; Tian, W.; Cao, Y.; Qin, Y.; Kim, J.; Roeder, R.G.; Patel, D.J.; et al. Transcriptional elongation factor Paf1 core complex adopts a spirally wrapped solenoidal topology. Proc. Natl. Acad. Sci. USA 2018, 115, 9998–10003. [Google Scholar] [CrossRef] [Green Version]
- Moon, S.D.; Park, J.H.; Kim, E.M.; Kim, J.H.; Han, J.H.; Yoo, S.J.; Yoon, K.H.; Kang, M.I.; Lee, K.W.; Son, H.Y.; et al. A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J. Clin. Endocrinol. Metab. 2005, 90, 878–883. [Google Scholar] [CrossRef] [Green Version]
- Moon, S.; Kim, J.H.; Shim, J.Y.; Ahn, Y.B.; Song, K.H.; Cha, B.Y.; Maeng, L.S.; Han, J.H. Analysis of aberrantly spliced HRPT2 transcripts and the resulting proteins in HPT-JT syndrome. Mol. Genet. Metab 2010, 100, 365–371. [Google Scholar] [CrossRef] [PubMed]
- Bohley, P. The fates of proteins in cells. Naturwissenschaften 1995, 82, 544–550. [Google Scholar] [CrossRef]
- Goldberg, A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 2003, 426, 895–899. [Google Scholar] [CrossRef]
- Sun, H.Y.; Kim, N.; Hwang, C.S.; Yoo, J.Y. Protein Degradation of RNA Polymerase II-Association Factor 1(PAF1) Is Controlled by CNOT4 and 26S Proteasome. PLoS ONE 2015, 10, e0125599. [Google Scholar] [CrossRef]
- Rubinsztein, D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443, 780–786. [Google Scholar] [CrossRef]
- Clague, M.J.; Urbe, S. Ubiquitin: Same molecule, different degradation pathways. Cell 2010, 143, 682–685. [Google Scholar] [CrossRef] [Green Version]
- Kwon, S.K.; Lee, D.H.; Kim, S.Y.; Park, J.H.; Choi, J.; Baek, K.H. Ubiquitin-specific protease 21 regulating the K48-linked polyubiquitination of NANOG. Biochem. Biophys. Res. Commun. 2017, 482, 1443–1448. [Google Scholar] [CrossRef]
- Suresh, B.; Lee, J.; Kim, K.S.; Ramakrishna, S. The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming. Stem Cells Int. 2016, 2016, 6705927. [Google Scholar] [CrossRef] [Green Version]
- Rivard, C.; Bazzaro, M. Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe. Methods Mol. Biol. 2015, 1249, 193–200. [Google Scholar] [CrossRef]
- Amrani, N.; Sachs, M.S.; Jacobson, A. Early nonsense: mRNA decay solves a translational problem. Nat. Rev. Mol. Cell. Biol. 2006, 7, 415–425. [Google Scholar] [CrossRef]
- Baker, K.E.; Parker, R. Nonsense-mediated mRNA decay: Terminating erroneous gene expression. Curr. Opin. Cell Biol. 2004, 16, 293–299. [Google Scholar] [CrossRef]
- Brogna, S.; Wen, J. Nonsense-mediated mRNA decay (NMD) mechanisms. Nat. Struct. Mol. Biol. 2009, 16, 107–113. [Google Scholar] [CrossRef]
- Manczyk, N.; Veggiani, G.; Teyra, J.; Strilchuk, A.W.; Sidhu, S.S.; Sicheri, F. The ubiquitin interacting motifs of USP37 act on the proximal Ub of a di-Ub chain to enhance catalytic efficiency. Sci. Rep. 2019, 9, 4119. [Google Scholar] [CrossRef]
- Abdul Rehman, S.A.; Kristariyanto, Y.A.; Choi, S.Y.; Nkosi, P.J.; Weidlich, S.; Labib, K.; Hofmann, K.; Kulathu, Y. MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes. Mol. Cell 2016, 63, 146–155. [Google Scholar] [CrossRef] [Green Version]
- Haahr, P.; Borgermann, N.; Guo, X.; Typas, D.; Achuthankutty, D.; Hoffmann, S.; Shearer, R.; Sixma, T.K.; Mailand, N. ZUFSP Deubiquitylates K63-Linked Polyubiquitin Chains to Promote Genome Stability. Mol. Cell 2018, 70, 165–174.e166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hermanns, T.; Pichlo, C.; Woiwode, I.; Klopffleisch, K.; Witting, K.F.; Ovaa, H.; Baumann, U.; Hofmann, K. A family of unconventional deubiquitinases with modular chain specificity determinants. Nat. Commun. 2018, 9, 799. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kwasna, D.; Abdul Rehman, S.A.; Natarajan, J.; Matthews, S.; Madden, R.; De Cesare, V.; Weidlich, S.; Virdee, S.; Ahel, I.; Gibbs-Seymour, I.; et al. Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability. Mol. Cell 2018, 70, 150–164.e156. [Google Scholar] [CrossRef] [Green Version]
- Tanno, H.; Shigematsu, T.; Nishikawa, S.; Hayakawa, A.; Denda, K.; Tanaka, T.; Komada, M. Ubiquitin-interacting motifs confer full catalytic activity, but not ubiquitin chain substrate specificity, to deubiquitinating enzyme USP37. J. Biol. Chem. 2014, 289, 2415–2423. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huang, X.; Summers, M.K.; Pham, V.; Lill, J.R.; Liu, J.; Lee, G.; Kirkpatrick, D.S.; Jackson, P.K.; Fang, G.; Dixit, V.M. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. Mol. Cell 2011, 42, 511–523. [Google Scholar] [CrossRef]
- Yeh, C.; Coyaud, E.; Bashkurov, M.; van der Lelij, P.; Cheung, S.W.; Peters, J.M.; Raught, B.; Pelletier, L. The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression. Curr. Biol. 2015, 25, 2290–2299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kim, S.Y.; Lee, J.-y.; Cho, Y.-j.; Jo, K.H.; Kim, E.S.; Han, J.H.; Baek, K.-H.; Moon, S.-d. USP37 Deubiquitinates CDC73 in HPT-JT Syndrome. Int. J. Mol. Sci. 2022, 23, 6364. https://doi.org/10.3390/ijms23126364
Kim SY, Lee J-y, Cho Y-j, Jo KH, Kim ES, Han JH, Baek K-H, Moon S-d. USP37 Deubiquitinates CDC73 in HPT-JT Syndrome. International Journal of Molecular Sciences. 2022; 23(12):6364. https://doi.org/10.3390/ijms23126364
Chicago/Turabian StyleKim, Su Yeon, Ji-young Lee, Yun-jung Cho, Kwan Hoon Jo, Eun Sook Kim, Je Ho Han, Kwang-Hyun Baek, and Sung-dae Moon. 2022. "USP37 Deubiquitinates CDC73 in HPT-JT Syndrome" International Journal of Molecular Sciences 23, no. 12: 6364. https://doi.org/10.3390/ijms23126364